In these STEP trials, most participants experienced mild to moderate symptoms, with the incidence of severe side effects being 9.8% in the semaglutide treatment group and 6.4% in the placebo group
Given that the two major defects in type 2 diabetes are insulin resistance and impaired insulin secretion, metformin is recommended for use in combination with insulin secretogogues and even with intensive insulin therapy [1]
Insurance coverage will ultimately determine real world affordability for most Canadians
doi: 10.1186/1475-2891-11-34 21
Available in a variety of delicious flavors as well as an unflavored option, it's an ideal choice for shakes, smoothies, coffee, or recipes when you want pure, high-quality protein without compromise
For companies across the pharmaceutical value chain, the opportunity is not just to follow the shift from injectables to oral delivery